CG Oncology Inc.
Leonard E Post (Director) sells CGON shares
About this filing
CG Oncology Inc. (CGON) filed Form 4 (insider transaction) with the SEC on Nov 17, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Leonard E Post · Director
Rule 10b5-1 plan · adopted Mar 5, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | M · exercise or conversion of a derivative | +1,000 | $0.60 | $600.00 | 1,000 | Direct |
| Nov 16, 2026 | S · open-market saleFootnotes F1 | −1,000 | $92.00 | $92,000.00 | 1,000 | Direct |
| Nov 16, 2026 | M · exercise or conversion of a derivativeDirector Stock Option (right to buy)Footnotes F2 | −1,000 | $0.00 | $0.00 | 101,077 | Direct |
Footnotes
- F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026.
- F2 Fully vested
More CGON filings
- 8-K
Filed Nov 16, 2026
- 10-Q
Filed Nov 6, 2026
- 8-K
Filed Nov 6, 2026
- 4
Filed Oct 19, 2026
- 4
Filed Oct 19, 2026
- 3
Filed Oct 19, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.